期刊文献+

戊酸雌二醇有助于宫颈扩张棒取出绝经期妇女宫内节育器 被引量:1

Estradiol valerate helpful for the removal of postmenopausal women IUD
暂未订购
导出
摘要 目的:探讨戊酸雌二醇结合1次性宫颈扩张棒取出绝经期妇女宫内节育器的临床效果。方法:宫内有节育器的绝经期妇女240例,随机分为对照组(n=120)和观察组(n=120)。观察组术前口服戊酸雌二醇7 d后,使用1次性宫颈扩张棒取出宫内节育器。对照组直接或用金属扩张棒扩张宫颈后取宫内节育器。观察两组宫颈扩张程度、镇痛效果、取出宫内节育器效果。结果:观察组镇痛、取出宫内节育器效果高于对照组,差异有统计学意义(P<0.05)。两组不良反应没有明显差别。结论:戊酸雌二醇有助于宫颈扩张棒取出绝经期妇女宫内节育器,安全有效。 Objective:To investigate the clinical effect of estradiol valerate combined with one-time cervical dilatation rods for the removal of intrauterine device(IUD)in postmenopausal women.Methods:240 cases of postmenopausal women with IUD were randomly divided into control group(n=120)and observation group(n=120).The observation group was treated with oral estradiol valerate for 7 d before operation,and then the IUD was removed by one-time cervical dilatation rods.In the control group,the IUDs were directly removed,or using metal expansion rods to expand the cervix and then removed.The degree of cervical dilatation,analgesic effect and the effect of IUD removal were observed in the two groups.Results:The effects of analgesia and IUD removal were higher in the observation group than in the control group,the difference was statistically significant(P〈0.05).There were no significant adverse reactions between two groups.Conclusion:Estradiol valerate is helpful for the removal of postmenopausal women IUD with cervical dilatation rod,and it is safe and effective.
作者 孙青 SUN Qing(Beihai City Population and Family Planning Service Center,Beihai 536000,China)
出处 《华夏医学》 CAS 2017年第1期51-54,共4页 Acta Medicinae Sinica
关键词 戊酸雌二醇 宫颈扩张棒 绝经期妇女 宫内节育器 estradiol valerate cervical dilatation rod postmenopausal women intrauterine device
  • 相关文献

参考文献5

二级参考文献45

  • 1刘征丽,李宏芳,霍玉芝,张延,韩华,金畅.一次性宫颈扩张棒在人工流产中的应用[J].陕西医学杂志,2004,33(11):1058-1059. 被引量:3
  • 2张立岩,孙选.米索前列醇联合利多卡因在人工流产术中的应用[J].中国计划生育学杂志,2004,12(12):753-754. 被引量:45
  • 3于庆珍,郭连俊,杨文东.绝经后妇女摘取宫内节育器的临床观察[J].中国妇幼健康研究,2007,18(1):32-34. 被引量:5
  • 4中华医学会妇产科学分会绝经学组.绝经过渡期和绝经后激素补充治疗临床应用指南.中华妇产科杂志,2010,45(7):635-637.
  • 5Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women 's Health Initiative randomized controlled trial[ J]. JAMA,2002, 288:321-333.
  • 6Van deWeijer PH, Mattsson LA, Ylikorkala O. Benefits and risks of long-term low-dose oral continuous combined hormone therapy[ J]. Maturitas, 2007,56(3 ):231-248.
  • 7Ettinger B. Rationale for use of lower estrogen doses for postmenopausal hormone therapy[ J]. Maturitas ,2007,57 ( 1 ) :81-84.
  • 8Langer RD. Efficacy, safety, and tolerability of low-dose hormone therapy in managing menopausal symptoms [ J ]. J Am Board Fam Med ,2009,22 ( 5 ) :563-573.
  • 9Rozenbaum H. How to evaluate the risk-benefit ratio of the lowdose hormone replacement therapy? [ J ]. J Steroid Biochem Mol Biol,2006,102( 1-5 ) :256-260.
  • 10Board of the International Menopause Society, Pines A, Sturdee DW, et al. Updated recommendations on postmenopausal hormone therapy[ J]. Climacteric ,2007,10( 3 ) : 181-194.

共引文献25

同被引文献12

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部